ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,277.51
0.80%
US Tech 100
18,064.80
0.02%
다우존스 지수
38,686.32
1.51%
Bitcoin
67,689.78
0.31%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Seelos Therapeutics Inc (SEEL)

  7. Seelos Therapeutics Inc (SEEL) 뉴스

SEEL

Seelos Therapeutics (SEEL)

Seelos Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:SEEL
일자시간출처헤드라인심볼기업
2024/06/0105:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
2024/05/2205:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
2024/05/2105:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
2024/05/1622:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
2024/05/1500:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
2024/05/1421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEELSeelos Therapeutics Inc
2024/03/0707:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SEELSeelos Therapeutics Inc
2024/03/0706:50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SEELSeelos Therapeutics Inc
2024/03/0207:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
2024/02/1506:50Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SEELSeelos Therapeutics Inc
2024/02/0707:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SEELSeelos Therapeutics Inc
2024/02/0220:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
2024/01/3106:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
2024/01/3020:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SEELSeelos Therapeutics Inc
2024/01/2222:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
2024/01/1811:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
2024/01/1811:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
2024/01/1106:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEELSeelos Therapeutics Inc
2024/01/0911:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
2024/01/0911:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
2024/01/0911:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
2024/01/0911:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEELSeelos Therapeutics Inc
2024/01/0222:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
2023/12/2814:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SEELSeelos Therapeutics Inc
2023/12/2306:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
2023/12/2222:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
2023/12/2106:59Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
2023/12/2106:54Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SEELSeelos Therapeutics Inc
2023/12/1906:54Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:SEELSeelos Therapeutics Inc
2023/12/1606:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SEELSeelos Therapeutics Inc
 검색 관련기사 보기:NASDAQ:SEEL

최근 히스토리

BIT
P1QSV5
BNP Paribas Issuance
BIT
P1LJK8
BNP Paribas Issuance
EU
Q667S
Q667S
BIT
P21JI3
NLBNPIT21JI3 20241218 2000
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유